ABCL Market Cap History
Below is a table of the ABCL market cap history going back to 12/11/2020:

Date ABCL Market Cap
12/11/202015.66B
3/23/20217.88B

Also see: ABCL Shares Outstanding History
and ABCL YTD Return
ABCL Historical Market Cap:
-179.65% CAGR
ABCL Historical Market Cap: +-179.65% CAGR

Mouse over chart for data details
12/11/20203/23/2021
AbCellera is a Vancouver, British Columbia-based biotechnology firm that researches and develops human antibodies to address pandemics and common diseases. Co.'s full-stack, artificial intelligence-, or AI, powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. Rather than advancing its own clinical pipeline of drug candidates, Co. forges partnerships with drug developers of all sizes, from pharmaceutical to small biotechnology companies. In a collaboration with Eli Lilly and Company, Co. has applied its technology stack to co-develop LY-CoV555, a potential antibody therapy to treat and prevent COVID-19. We show 2 historical shares outstanding datapoints in our ABCL shares outstanding history coverage, used to compute ABCL market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ABCL market cap history over the course of time is important for investors interested in comparing ABCL's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ABCL versus a peer is one thing; comparing ABCL market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ABCL can fluctuate over the course of history. With this page we aim to empower investors researching ABCL by allowing them to research the ABCL market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ABCL:
ABCL SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AbCellera Biologics (ABCL) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ABEV Market Cap History
ABGI Market Cap History
ABIL Market Cap History
ABNB Market Cap History
ABUS Market Cap History
ACA Market Cap History
ACAM Market Cap History
ACB Market Cap History
ACCD Market Cap History
ACEL Market Cap History
More Miscellaneous companies »

 

ABCL Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.